Researchers found that two-thirds of children with rare autoimmune diseases experienced some additional symptoms, which were not formally associated with antiphospholipid syndrome (APS).
Each year, around two of every 100,000 American adults receive a new diagnosis of antiphospholipid syndrome, or APS, an autoimmune disease known to cause inflammation and recurring, potentially fatal, blood clots.